文献速递甲状腺疾病

甲状腺功能亢进与出生缺陷:母体甲状腺功能及甲状腺自身抗体阳性的作用

Hyperthyroidism and Birth Defects: The Roles of Maternal Thyroid Function and Thyroid Autoantibody Positivity.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

基于丹麦两个队列20 399名无已知甲状腺疾病孕妇的回顾性队列研究,评估孕早期母体甲状腺功能、甲状腺自身抗体与出生缺陷的关联。结果显示母体TSH和游离T4与出生缺陷无关,甲状腺过氧化物酶抗体或甲状腺球蛋白抗体阳性者出生缺陷患病率与阴性者相似,但促甲状腺激素受体抗体或甲状腺刺激性免疫球蛋白阳性者出生缺陷患病率较高。结论认为孕早期母体甲状腺功能与出生缺陷风险无关,而与甲状腺刺激性抗体的可能关联需进一步研究。

要点

  • 孕早期母体TSH和游离T4水平与出生缺陷风险无关。
  • 甲状腺过氧化物酶抗体或甲状腺球蛋白抗体阳性与出生缺陷患病率无关。
  • 促甲状腺激素受体抗体或甲状腺刺激性免疫球蛋白阳性者出生缺陷患病率较高,需进一步研究。

核心结论

  • 孕早期母体甲状腺功能与出生缺陷风险无关。
  • 促甲状腺激素受体抗体或甲状腺刺激性免疫球蛋白阳性与出生缺陷的关联值得进一步研究。

研究设计与样本

  • 回顾性队列研究,纳入丹麦国家出生队列和北丹麦地区妊娠队列中20 399名无已知甲状腺疾病的孕妇及其子女。
  • 孕早期(中位孕10周)血样检测母体TSH和游离T4(两队列均检测),以及甲状腺过氧化物酶抗体、甲状腺球蛋白抗体、促甲状腺激素受体抗体和甲状腺刺激性免疫球蛋白(仅北丹麦地区妊娠队列检测)。
  • 出生缺陷信息来自医院诊断。

主要发现

  • 702名儿童(3.4%)存在出生缺陷。
  • 有出生缺陷与无出生缺陷者的母体TSH中位数分别为1.19 mIU/L和1.13 mIU/L(P = .1),游离T4中位数分别为15.7 pmol/L和15.5 pmol/L(P = .3)。
  • 甲状腺过氧化物酶抗体或甲状腺球蛋白抗体阳性者子女出生缺陷患病率为4.3%,阴性者为4.0%(P = .6)。
  • 促甲状腺激素受体抗体或甲状腺刺激性免疫球蛋白阳性者子女出生缺陷患病率为9.5%(P = .003)。

临床怎么用

  • 对于无已知甲状腺疾病的孕妇,孕早期甲状腺功能检测结果不应用于评估出生缺陷风险。
  • 对促甲状腺激素受体抗体或甲状腺刺激性免疫球蛋白阳性的孕妇,需关注子代出生缺陷风险,但尚需进一步研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: An increased risk of birth defects in children born to mothers with hyperthyroidism has been found, and uncertainties prevail on the role of maternal thyroid function and thyroid autoimmunity. OBJECTIVE: To evaluate the association between maternal thyroid function, thyroid autoantibodies, and birth defects. METHODS: Retrospective cohort study of 20 399 pregnant women with no known thyroid disease and their children from the Danish National Birth Cohort and the North Denmark Region Pregnancy Cohort. Blood samples from early pregnancy (median week 10) were assessed for maternal TSH and free T4 in both cohorts and for thyroid peroxidase antibodies and thyroglobulin antibodies as well as TSH receptor antibodies and thyroid stimulating immunoglobulin in the North Denmark Region Pregnancy Cohort. Information on birth defects was retrieved from hospital diagnoses. RESULTS: Altogether 702 children (3.4%) had birth defects, and maternal median TSH (no birth defects: 1.13 mIU/L; birth defects: 1.19 mIU/L; P = .1) and free T4 (no birth defects: 15.5 pmol/L; birth defects: 15.7 pmol/L; P = .3) did not differ by outcome of birth defect. The prevalence of birth defects was similar in children born to mothers who were thyroid peroxidase antibodies- or thyroglobulin antibodies-positive (4.3%) or negative (4.0%; P = .6) but higher (9.5%) when the mother was positive for TSH receptor antibodies or thyroid stimulating immunoglobulin (P = .003). CONCLUSION: In a large Danish pregnancy cohort, no evidence was found that maternal thyroid function in early pregnancy is associated with a risk of birth defects. A possible link with maternal thyroid stimulating antibodies warrants further investigation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Andersen SL, Torp NMU, Vestergaard P, et al. Hyperthyroidism and Birth Defects: The Roles of Maternal Thyroid Function and Thyroid Autoantibody Positivity. J Clin Endocrinol Metab. 2026. PMID: 41639978. doi:10.1210/clinem/dgag046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。